Logo
Logo


ISSN: 0300-9041
ISSNe: 2594-2034


Indizada en: SciELO, Índice Médico Latinoamericano, LILACS, Medline
Editada por la Federación Mexicana de Colegios de Obstetricia, y Ginecologia AC
Fundada por la Asociación Mexicana de Ginecología y Obstetricia en 1945
 

INFORMACIÓN EXCLUSIVA PARA LOS PROFESIONALES DE LA SALUD


Periodicidad: continua
Abreviatura: Ginecol Obstet Mex
ISSN: 0300-9041
ISSNe: 2594-2034
Indizada en: Scimago, Índice Médico Latinoamericano, Lilacs, Medline, Science Citation Index, Ulrich, Ebsco.

Tratamiento del cáncer de mama en la mujer embarazada: caso clínico

Treatment of breast cancer in pregnant women: clinical case.

Ginecol Obstet Mex. 2019 mayo;87(5):324-333.

https://doi.org/10.24245/gom.v87i5.2811

María Montaño-Serrano, Sara Rojo-Novo, Rosa Albalat-Fernández, Juan Novo-Cabrera, Manolo La Calle-Marcos

Unidad de Gestión Clínica de Obstetricia y Ginecología, Hospital Universitario Virgen Macarena de Sevilla, España.


Corrrespondencia:

Sara Rojo Novo
sararn677@hotmail.com

Debe citarse como:

Montaño-Serrano M, Rojo-Novo S, Albalat-Fernández R, Novo-Cabrera J, La Calle-Marcos M. Tratamiento del cáncer de mama en la mujer embarazada: caso clínico. Ginecol Obstet Mex. 2019 mayo;87(5):324-333. https://doi.org/10.24245/gom.v87i5.2811

Resumen

ANTECEDENTES: El cáncer de mama es la principal neoplasia diagnosticada durante el embarazo y posparto. La incidencia durante el embarazo varía de 0.2-2.6%. El tratamiento implica un reto para los sistemas de salud porque debe valorarse y salvaguardarse el bienestar de la madre y su hijo.

CASO CLÍNICO: Paciente de 26 años, que acudió a consulta por mastalgia derecha, con crecimiento rápido a partir del inicio del embarazo. Durante la exploración mamaria se evidenció una tumoración de consistencia dura, de 8 cm, que ocupaba ambos cuadrantes superiores de la mama derecha, con enrojecimiento de la piel. La ecografía reportó una tumoración sólido-quística heterogénea, de 8 x 5 cm, sin ganglios patológicos axilares. El estudio anatomopatológico de la biopsia reportó un carcinoma infiltrante, con inmunofenotipo triple negativo (inmunorreactividad negativa para receptores de estrógenos y progesterona, y Her-2 con índice de proliferación Ki67 de 80%), con lo que se confirmó el diagnóstico de cáncer de mama localmente avanzado en el segundo trimestre del embarazo. Después de la administración de tres ciclos de quimioterapia neoadyuvante con antraciclinas (doxorrubicina y ciclofosfamida) cada tres semanas, se indicó la finalización del embarazo mediante la inducción del parto en la semana 36 + 6. Nació un varón de 2800 g, con Apgar 9-10-10. La madre y su hijo evolucionaron satisfactoriamente, por lo que recibieron el alta hospitalaria 4 días posteriores a la intervención. A 10 meses de la mastectomía la paciente goza de buena salud física y psicológica, al igual que su hijo de 15 meses, y continúa en seguimiento estrecho en el servicio de Oncología.

CONCLUSIÓN: El tratamiento del cáncer de mama durante el embarazo es seguro y ofrece buenos resultados a largo plazo. Es importante la intervención y valoración multidisciplinaria, además de la asesoría correcta y el apoyo psicológico a la familia.

PALABRAS CLAVE: Cáncer de mama; embarazo; radioterapia; quimioterapia, biopsia selectiva del ganglio centinela; mastectomía.

Abstract

BACKGROUND: Breast cancer is the most prevalent cancer nowadays and is the most common at the pregnancy and postpartum period. The incidence is between 0.2-2.6% and is currently increasing due to delayed childbearing. The treatment implies a challenge for the health systems because the welfare of the mother and her child must be valued and safeguarded.

CLINICAL CASE: A 26-year-old patient who attended the consultation for right mastalgia, with rapid growth from the beginning of pregnancy. During the mammary examination, a hard consistency tumor of 8 cm was observed, occupying both upper quadrants of the right breast, with reddening of the skin. The ultrasound revealed a heterogeneous solid-cystic tumor, 8 x 5 cm, without pathological axillary lymph nodes. The anatomopathological study of the biopsy reported an infiltrating carcinoma, with triple negative immunophenotype (negative immunoreactivity for estrogen and progesterone receptors, and Her-2 with Ki67 proliferation index of 80%), which confirmed the diagnosis of breast cancer locally advanced in the second trimester of pregnancy. After administration of three cycles of neoadjuvant chemotherapy with anthracyclines (doxorubicin and cyclophosphamide) trisemanales, termination of pregnancy was indicated by induction of labor at week 36 + 6. A male was born at 2800 g, with Apgar 9-10- 10 The mother and her son evolved satisfactorily, so they were discharged 4 days after the intervention. Ten months after mastectomy, she enjoys good physical and psycho-logical health, as does her 15-month-old son. Continues in close monitoring in the Oncology service.

CONCLUSIONS: The treatment of breast cancer during pregnancy is safe and offers good long-term results. The important intervention and multidisciplinary assessment, in addition to the correct advice and psychological support to the family.

KEYWORDS: Breast cancer; Pregnancy; Radiotherapy; Chemotherapy; Sentinel lymph node biopsy; Mastectomy.

    1. Álvarez-Tapias C, et al. Actualización del manejo clínico del cáncer mamario asociado al embarazo. Revisión de la Literatura. Rev Colomb Salud Libre 2017;(2):50-59. http://doi.org/10.1016/j.rccan.2017.02.018
    2. Shim M, et al. Clinical characteristics and outcome of cancer diagnosed during pregnancy. Obstet Gynecol Sci. 2016;59(1):1-8. http://doi.org/10.5468/ogs.2016.59.1.1
    3. Shlensky V, et al. Management of Breast Cancer during Pregnancy: Are We Compliant with Current Guidelines?. Am J Perinatol Rep. 2017;7(1):39-43. http://doi.org/10.1055/s-0037-1599133
    4. Sule E, et al. Management of pregnancy associated breast cancer with chemotherapy in a developing country. Int J Surg Case Rep 2015;17:117-120. http://doi.org/10.1016/j.ijscr.2015.10.008
    5. Albalat-Fernández R, et al. Biopsia selectiva de ganglio centinela en mujer embarazada con cáncer de mama. Prog Obstet Ginecol. 2015;58(6):283-286. http://doi.org/10.1016/j.pog.2015.02.008
    6. Hernández-Blanquisett A, et al. Breast cancer in pregnancy: an institutional experience. Ecancermedicalscience. 2015;9:551. http://doi.org/10.3332/ecancer.2015.551
    7. Rovera F, et al. Breast cancer in pregnancy. Breast J 2010;16(Suppl 1). http://doi.org/10.1111/j.1524-4741.2010.00998.x
    8. Simonescu A, et al. Advanced metastatic breast cancer in pregnancy: the imperative of physical breast examination in pregnancy. Rom J Morphol Embryol 2017;58(2):645-650. http://www.rjme.ro/RJME/resources/files/580217645650.pdf
    9. Upadhayay R, et al. Triple negative breast cancer in pregnancy and postpartum: two case reports in hispanic women. Case Rep Obstet Gynecol 2015;2015:856931. http://doi.org/10.1155/2015/856931
    10. Zagouri F, et al. Cancer in pregnancy: disentangling treatment modalities. ESMO Open. 2016;1(3). http://doi.org/10.1136/esmoopen-2015-000016
    11. Ye X, et al. Study on the adverse effects following chemotherapy for breast cancer diagnosis during pregnancy. Medicine 2017;96(46). http://doi.org/10.1097/MD.0000000000008582
    12. Nargotra N, et al. Pregnancy associated breast cancer: awareness is the key to diagnosis-a case report. J Clin Diagn Res 2015;9(11):9-11. http://doi.org/10.7860/JCDR/2015/15022.6832
    13. International Commission on Radiological Protection. Pregnancy and medical radiation. Ann ICRP 2000;30(1), 1-43.
    14. DeSantis CE, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 2014;64(4):252-71. http://doi.org/10.3322/caac.21235
    15. Amant F, et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. The Lancet Oncology, 2012; 13(3):256-264. http://doi.org/10.1016/S1470-2045(11)70363-1
    16. Litton JK, et al. Breast cancer and pregnancy: current concepts in diagnosis and treatment. Oncologist 2010;15(12):1238-47. http://doi.org/10.1634/theoncologist.2010-0262
    17. Peccatori F, et al. Cancer, pregnancy and fertility: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;(Suppl 6):160-70. http://doi.org/10.1093/annonc/mdt199
    18. Calsteren KV, et al. Transplacental transfer of paclitaxel, docetaxel, carboplatin, and trastuzumab in a baboon model. Int J Gynecol Cancer 2010;20:1456-64. http://doi.org/10.1111/IGC.0b013e3181fb18c8
    19. Loibl S, et al. Treatment of breast cancer during pregnancy: an observational study. The Lancet Oncology 2012;13(9):887-896. http://doi.org/10.1016/S1470-2045(12)70261-9
    20. Zagouri F, et al. Trastuzumab administration during pregnancy: a systematic review and meta-analysis. Breast Cancer Res Treat 2013;137:349-57. http://doi.org/10.1007/s10549-012-2368-y
    21. Amant F, et al. Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol 2013;31(20):2532-2539. http://doi.org/10.1200/JCO.2012.45.6335
    22. Gentilini O, et al. Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 2004;15:1348-51. http://doi.org/10.1093/annonc/mdh355

Comentarios